9.15
0.00
(0.00%)
As of January 29 at 8:06:59 AM GMT+1. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.27M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| HARFORD SIMON N R Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| PROUT SAMANTHA WHITEMAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| CLARK DAVID MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| CASTELLI JEFFREY P Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| ROSENBERG ELLEN S Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Dec 2, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.02 per share. | Direct | 75,124 | Dec 2, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 12.28 per share. | Direct | 97,024 | Nov 6, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 12.50 per share. | Direct | 98,800 | Nov 6, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Nov 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 11.46 per share. | Direct | 85,960 | Nov 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Oct 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.60 per share. | Direct | 79,492 | Oct 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Sep 3, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 11.71 per share. | Direct | 87,798 | Sep 3, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Aug 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.34 per share. | Direct | 77,518 | Aug 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 52,521 | Jul 5, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.00 per share. | Direct | 61,029 | Jul 5, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 12,054 | Jul 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.00 per share. | Direct | 14,003 | Jul 1, 2024 |
| MCGLYNN MARGARET G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ROBERTS EIRY WYN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| KELLY MICHAEL AARON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| SBLENDORIO GLENN P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| WHITMAN BURKE W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| WHEELER CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| RAAB MICHAEL G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| BLEIL LYNN DORSEY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Jun 3, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.00 per share. | Direct | 75,000 | Jun 3, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | May 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 10.07 per share. | Direct | 75,524 | May 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 per share. | Direct | 64,575 | Apr 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 11.67 per share. | Direct | 87,496 | Apr 1, 2024 |
| SBLENDORIO GLENN P Director | Conversion of Exercise of derivative security at price 2.80 per share. | Direct | 42,000 | Mar 7, 2024 |
| MCGLYNN MARGARET G Director | Conversion of Exercise of derivative security at price 2.80 per share. | Direct | 42,000 | Mar 5, 2024 |
| RAAB MICHAEL G Director | Conversion of Exercise of derivative security at price 2.80 per share. | Direct | 42,000 | Mar 5, 2024 |
| MCGLYNN MARGARET G Director | Sale at price 13.29 - 13.40 per share. | Direct | 200,175 | Mar 5, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 - 12.28 per share. | Direct | 166,904 | Mar 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 13.14 per share. | Direct | 208,017 | Mar 1, 2024 |
| CROWLEY JOHN FRANCIS Officer and Director | Sale at price 13.35 per share. | Direct | 389,543 | Mar 1, 2024 |
| CLARK DAVID MICHAEL Officer | Sale at price 14.00 per share. | Direct | 61,978 | Feb 15, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 14.00 per share. | Direct | 58,338 | Feb 15, 2024 |
| CROWLEY JOHN FRANCIS Officer and Director | Sale at price 13.81 per share. | Direct | 436,551 | Feb 15, 2024 |
| ROSENBERG ELLEN S Officer | Conversion of Exercise of derivative security at price 5.16 per share. | Direct | 154,800 | Feb 7, 2024 |
| ROSENBERG ELLEN S Officer | Sale at price 13.00 per share. | Direct | 390,018 | Feb 7, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Conversion of Exercise of derivative security at price 8.61 - 12.28 per share. | Direct | 166,904 | Feb 1, 2024 |
| CAMPBELL BRADLEY LEWIS Chief Executive Officer | Sale at price 12.56 per share. | Direct | 198,858 | Feb 1, 2024 |
Related Tickers
APE1.SG Addex Therapeutics Ltd
7.25
0.00%
42Z.DU Revolution Medicines Inc
39.00
0.00%
ISI.BE Ionis Pharmaceuticals Inc
32.43
+0.50%
ISI.DU Ionis Pharmaceuticals Inc
31.53
-3.58%
4DN.MU Denali Therapeutics Inc.
22.29
+1.64%
2GH.MU Merus NV
39.00
0.00%
IONS.MX Ionis Pharmaceuticals, Inc.
673.00
0.00%
ISI.SG Ionis Pharmaceuticals Inc
31.17
0.00%
ISI.MU Ionis Pharmaceuticals Inc
32.86
0.00%
2GH.BE Merus NV
40.00
+3.09%